Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
short-term repeated dose toxicity: dermal
Remarks:
READ-across with Oxirane, (butoxymethyl)- (n-Butyl glycidyl ether) CAS: 2426-08-6
Type of information:
(Q)SAR
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
data from handbook or collection of data
Justification for type of information:
It is in the QSAR summary report: READ-across with Oxirane, (butoxymethyl)- (n-Butyl glycidyl ether) CAS: 2426-08-6

Data source

Reference
Reference Type:
review article or handbook
Title:
Unnamed
Year:
2010
Report date:
2010

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
It is in a screening assessment prepared by Canadian authority.
GLP compliance:
not specified
Remarks:
It is not mentioned if the test was done in a GLP laboratory or not.

Test material

1
Chemical structure
Reference substance name:
Butyl 2,3-epoxypropyl ether
EC Number:
219-376-4
EC Name:
Butyl 2,3-epoxypropyl ether
Cas Number:
2426-08-6
Molecular formula:
C7H14O2
IUPAC Name:
2-(butoxymethyl)oxirane
Test material form:
not specified

Test animals

Species:
rabbit
Strain:
not specified

Results and discussion

Effect levels

Key result
Dose descriptor:
LOEL
Effect level:
ca. 100 mg/kg bw/day
Based on:
test mat.
Basis for effect level:
gross pathology

Target system / organ toxicity

Key result
Critical effects observed:
yes
Lowest effective dose / conc.:
100 mg/kg bw/day
System:
other: liver
Organ:
liver
Treatment related:
yes
Dose response relationship:
yes
Relevant for humans:
not specified

Applicant's summary and conclusion

Conclusions:
LOEL: 100 mg/kg-bw
Executive summary:

LOEL: 100 mg/kg-bw